210 results on '"Matsuo, Hidemasa"'
Search Results
2. Parbendazole as a promising drug for inducing differentiation of acute myeloid leukemia cells with various subtypes
3. Suppression of super-enhancer-driven TAL1 expression by KLF4 in T-cell acute lymphoblastic leukemia
4. Landscape of driver mutations and their clinical effects on Down syndrome–related myeloid neoplasms
5. Successful allogeneic bone marrow transplantation in a case of variant acute promyelocytic leukemia with ZBTB16-RARA
6. Author Correction: A RUNX-targeted gene switch-off approach modulates the BIRC5/PIF1-p21 pathway and reduces glioblastoma growth in mice
7. A RUNX-targeted gene switch-off approach modulates the BIRC5/PIF1-p21 pathway and reduces glioblastoma growth in mice
8. Machine learning-based prediction of relapse in rheumatoid arthritis patients using data on ultrasound examination and blood test
9. Positive rate and prognostic significance of the superb microvascular imaging signal in joints of rheumatoid arthritis patients in remission with normal C-reactive protein levels and erythrocyte sedimentation rates
10. Fusion partner–specific mutation profiles and KRAS mutations as adverse prognostic factors in MLL-rearranged AML
11. Inhibition of CDK4/6 and autophagy synergistically induces apoptosis in t(8;21) acute myeloid leukemia cells
12. Prediction of recurrence and remission using superb microvascular imaging in rheumatoid arthritis
13. Transcriptome analysis offers a comprehensive illustration of the genetic background of pediatric acute myeloid leukemia
14. Donor‐derived CD8‐predominant T cells in human graft‐versus‐host disease of the brain after allogeneic transplantation.
15. Label‐free cell detection of acute leukemia using ghost cytometry
16. P527: DISTINCTIVE CLONAL EVOLUTION PATTERN AND PROGNOSTIC SIGNIFICANCE OF THE CLONALITY OF KRAS MUTATIONS IN KMT2A-REARRANGED ACUTE MYELOID LEUKEMIA
17. Pivotal role of DPYSL2A in KLF4-mediated monocytic differentiation of acute myeloid leukemia cells
18. KRASG12 mutations as adverse prognostic factors in KMT2A-rearranged acute myeloid leukemia
19. Genetic regulation of the RUNX transcription factor family has antitumor effects
20. Purification of leukemic blast cells from blood smears using laser microdissection
21. RUNX1–Survivin Axis Is a Novel Therapeutic Target for Malignant Rhabdoid Tumors
22. Monitoring of fusion gene transcripts to predict relapse in pediatric acute myeloid leukemia
23. Multiplex fusion gene testing in pediatric acute myeloid leukemia
24. TP53 and RB1 alterations characterize poor prognostic subgroups in pediatric acute myeloid leukemia.
25. A RUNX-targeted gene switch-off approach modulates the BIRC5/PIF1-p21 pathway and reduces glioblastoma growth in mice
26. Machine learning-based prediction of relapse in rheumatoid arthritis patients using data on ultrasound examination and blood test
27. RUNX1 transactivates BCR-ABL1 expression in Philadelphia chromosome positive acute lymphoblastic leukemia
28. Fludarabine, cytarabine, granulocyte colony‐stimulating factor and idarubicin for relapsed childhood acute myeloid leukemia
29. Prediction of recurrence and remission using superb microvascular imaging in rheumatoid arthritis
30. CXCR4 Overexpression is a Poor Prognostic Factor in Pediatric Acute Myeloid Leukemia With Low Risk: A Report From the Japanese Pediatric Leukemia/Lymphoma Study Group
31. RUNX1 transactivates BCR‐ABL1 expression in Philadelphia chromosome positive acute lymphoblastic leukemia
32. Clonal Evolution Pattern and Prognostic Significance of Clonal Architecture in KMT2A-Rearranged Acute Myeloid Leukemia
33. Efficacy of a combination therapy targeting CDK4/6 and autophagy in a mouse xenograft model of t(8;21) acute myeloid leukemia
34. Albendazole induces the terminal differentiation of acute myeloid leukaemia cells to monocytes by stimulating the Krüppel‐like factor 4‐dihydropyrimidinase‐like 2A (KLF4‐DPYSL2A) axis
35. Efficacy of a combination therapy targeting CDK4/6 and autophagy in a mouse xenograft model of t(8;21) acute myeloid leukemia
36. RUNX inhibitor suppresses graft‐versus‐host disease through targeting RUNX‐NFATC2 axis
37. Suppression of Super-Enhancer-Driven TAL1 Expression By KLF4 in T-Cell Acute Lymphoblastic Leukemia
38. Acute myeloid leukaemia with myelodysplastic features in children: a report of Japanese Paediatric Leukaemia/Lymphoma Study Group
39. Suppression of super-enhancer-driven TAL1expression by KLF4 in T-cell acute lymphoblastic leukemia
40. Droplet digital polymerase chain reaction assay for the detection of the minor clone of KIT D816V in paediatric acute myeloid leukaemia especially showing RUNX1‐RUNX1T1 transcripts
41. RUNX inhibitor suppresses graft‐versus‐host disease through targeting RUNX‐NFATC2 axis
42. Fusion partner–specific mutation profiles and KRAS mutations as adverse prognostic factors in MLL-rearranged AML
43. TXNIP induces growth arrest and enhances ABT263‐induced apoptosis in mixed‐lineage leukemia‐rearranged acute myeloid leukemia cells
44. Clinical significance of RAS pathway alterations in pediatric acute myeloid leukemia
45. RUNX-NFAT Axis As a Novel Therapeutic Target for AML and T Cell Immunity
46. KRAS mutations Frequently Coexist with High-Risk MLL Fusions and Are Independent Adverse Prognostic Factors in MLL-Rearranged Acute Myeloid Leukemia
47. Autophagy Inhibition Enhances CDK4/6 Inhibitor-Induced Apoptosis in t(8;21) Acute Myeloid Leukemia Cells
48. Blast cells in acute megakaryoblastic leukaemia with Down syndrome are characterized by low CLEC12A expression
49. Inhibition of CDK4/6 and autophagy synergistically induces apoptosis in t(8;21) acute myeloid leukemia cells
50. TXNIP induces growth arrest and enhances ABT263‐induced apoptosis in mixed‐lineage leukemia‐rearranged acute myeloid leukemia cells
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.